Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Chimeric antigen receptor–modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whether chimeric antigen receptor T cells have clinical activity in acute lymphoblastic leukemia (ALL). Two children with relap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grupp, Stephan A., Kalos, Michael, Barrett, David, Aplenc, Richard, Porter, David L., Rheingold, Susan R., Teachey, David T., Chew, Anne, Hauck, Bernd, Wright, J. Fraser, Milone, Michael C., Levine, Bruce L., June, Carl H.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058440/
https://ncbi.nlm.nih.gov/pubmed/23527958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1215134
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares